RANK receptor
Also called: receptor activator of nuclear factor kappa-B, RANK protein
What it means
RANK is a protein on bone-cell precursors that, when activated, tells them to turn into osteoclasts, the cells that break down bone.
This receptor controls how much bone-breakdown activity happens, so it directly affects whether your bones gain or lose density over time.
RANK sits on the surface of cells that become osteoclasts, the cells that break down old bone. When a signaling protein called RANKL attaches to RANK, it switches on a chain of events inside the cell that turns it into a mature, active bone-resorbing osteoclast. This is one of the main "go" signals in the bone remodeling cycle.
Your body balances this system with a decoy protein called OPG, which can grab RANKL before it reaches RANK, acting like a brake. Normally bone building and bone breakdown stay fairly balanced. But if RANKL activity outpaces OPG, more RANK receptors get switched on, osteoclast activity rises, and bone can be lost faster than it's rebuilt.
This pathway matters because some osteoporosis medications work by blocking it. Denosumab, for example, is a man-made antibody that binds RANKL so it can't activate RANK, which reduces osteoclast formation and slows bone breakdown. Any decisions about starting, stopping, or switching this or similar medications should be made with your doctor, since timing and follow-up care matter.
The RANK receptor tells bone-cell precursors to become osteoclasts, directly shaping bone gain or loss.
Where this leads
WordWondering what actually switches RANK on? RANKL explains the signal that activates this receptor and is a target for some osteoporosis medications.
Related words
RANKL is a signal that activates osteoclasts, the cells that break down bone, and it's a key target for some…
OPG (osteoprotegerin) is a protein made by bone-building cells that blocks a signal called RANKL, which helps slow…
Osteoclasts are the cells that break down old bone tissue, working alongside bone-building osteoblasts to constantly…
Osteoclastogenesis is the process where bone marrow cells turn into osteoclasts, the cells responsible for breaking…
Denosumab (Prolia) is a twice-yearly injection that blocks RANKL, a signal osteoclasts need to mature, slowing bone…
Bone remodeling is the lifelong cycle where cells called osteoclasts remove old bone and osteoblasts build new bone…
Education only, not medical advice. Decisions about tests, medications and treatment belong with your own doctor. OsteoStrong does not diagnose, treat or cure any disease.
